November 28, 2023 Experience Uber $1.725 billion convertible notes offering and capped call transactions The 0.875% convertible senior notes are due 2028
November 27, 2023 Experience Atara Biotherapeutics $100 million at-the-market offering The stock is listed on Nasdaq
September 13, 2023 Experience Equinix CHF 300 million bond offering We advised Equinix on a Regulation S bond offering
August 21, 2023 Experience AN2 Therapeutics $70 million follow-on offering The shares are listed on the Nasdaq Global Select Market
August 17, 2023 Experience RAPT Therapeutics $150 million at-the-market offering The shares are listed on the Nasdaq Global Market
July 10, 2023 Experience Monitronics International emerges from chapter 11 We advised the ad hoc lender group that negotiated and backstopped the restructuring
July 5, 2023 Experience Nextracker $662.5 million common stock offering We advised Nextracker on the SEC-registered secondary offering
June 30, 2023 Experience Lucid Group $232 million strategic supply agreement with Aston Martin We are advising Lucid Group on the transaction
June 5, 2023 Experience Lucid $3 billion public offering of stock and concurrent private placement We advised Lucid on the transactions